DUSP2 methylation is a candidate biomarker of outcome in head and neck cancer

BACKGROUND: Biomarkers predictive of response to chemoradiotherapy (CRT) regimens for locally advanced head and neck squamous cell carcinoma (LA-HNSCC) are urgently required to identify patients in whom this approach is likely to be effective. TP53 mutations and epidermal growth factor (EGFR) overex...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ann Transl Med
Autors principals: Lo Nigro, Cristiana, Vivenza, Daniela, Denaro, Nerina, Lattanzio, Laura, Fortunato, Mirella, Crook, Tim, Merlano, Marco Carlo
Format: Artigo
Idioma:Inglês
Publicat: AME Publishing Company 2018
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6064804/
https://ncbi.nlm.nih.gov/pubmed/30094257
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2018.06.39
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars